Results 41 to 50 of about 81,119 (304)

Acceptability and feasibility of HIV Pre-exposure prophylaxis (PrEP) in Southeast Asia: a scoping review

, 2023
This scoping review aims to examine the acceptability and feasibility of HIV Pre-exposure prophylaxis program in Southeast ...
Roueline Zantua, Rogie Royce Carandang, Chaia Alyssa M. Reyes, Czarina Mae Sitchon, Erla Grace Sarmiento   +4 more
core   +1 more source

The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective High‐altitude headache (HAH) is a common neurological condition associated with rapid ascent to high altitude. The pathophysiological mechanisms underlying HAH remain incompletely understood. Calcitonin gene‐related peptide (CGRP), a neuropeptide implicated in migraine pathophysiology, may play a key role in the pathophysiology of ...
Roman Schniepp, Ludwig Karrasch, Helena Breitenstein, Andreas Straube, Katharina Kamm   +4 more
wiley   +1 more source

Pre-exposure prophylaxis (PrEP) need met in PEPFAR-supported countries, by pre-COVID-19 and COVID-19 time periods and by country.

, 2022
Pre-exposure prophylaxis (PrEP) need met in PEPFAR-supported countries, by pre-COVID-19 and COVID-19 time periods and by country.
Pragna Patel (240863), Sangeeta Rana (779840), Sara Klucking (12354820), Gaston Djomand (12354811), Sharon Stash (12354814), Anindya K. De (12354805), Ryan Keating (5343593), Michael Kerzner (12354802), Randy Yee (12354808), Robyn Eakle (4607374), Allison Kimmel (12354817)   +10 more
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

A systematic review of adherence to oral pre-exposure prophylaxis for HIV – how can we improve uptake and adherence?

BMC Infectious Diseases, 2018
Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk of HIV transmission in high risk individuals. However, the effectiveness of oral pre-exposure prophylaxis is highly dependent on user adherence, which some ...
David Sidebottom, Anna Mia Ekström, Susanne Strömdahl   +2 more
doaj   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project

Frontiers in Public Health, 2017
IntroductionThe effectiveness of daily pre-exposure prophylaxis (PrEP) is well established. However, there has been increasing interest in non-daily dosing schedules among gay and bisexual men (GBM).
Stefanie J. Vaccher, Christopher Gianacas, David J. Templeton, David J. Templeton, Isobel M. Poynten, Bridget G. Haire, Catriona Ooi, Catriona Ooi, Rosalind Foster, Rosalind Foster, Anna McNulty, Anna McNulty, Andrew E. Grulich, Iryna B. Zablotska, On Behalf of the PRELUDE Study Team, Andrew Carr, Andrew Grulich, Anna McNulty, Brent Mackie, Cathy Pell, Catriona Ooi, Cheung (Yvonne) Ching, Chris Gianacas, David Templeton, Dean Murphy, Edwina Wright, Garrett Prestage, Isobel (Mary) Poynten, John de Wit, John Kaldor, John McAllister, Kenneth Mayer, Mark Bloch, Martin Holt, Nathan Ryder, Rebecca Guy, Rosalind Foster, Stefanie Vaccher   +37 more
doaj   +1 more source

Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm? [PDF]

Farmacia Hospitalaria, 2016
Pre-exposure prophylaxis” (PrEP) has been recently developed as a prevention strategy which involves the administration of drugs to non-infected individuals who present high exposure or susceptibility to HIV.
Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero   +1 more
doaj   +1 more source

Attributes of products for HIV Pre-Exposure Prophylaxis (PrEP).

, 2021
Attributes of products for HIV Pre-Exposure Prophylaxis (PrEP).
Mandeep Sekhon (3698575), Ariane van der Straten (230049)   +1 more
core   +1 more source

Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 44‐year‐old man presented with recurrent hypothermia, diaphoresis and hypertension. Extensive investigation for infectious, inflammatory, metabolic and endocrine aetiologies was negative. MR scan of the brain demonstrated no lesions but revealed callosal dysgenesis, consistent with Shapiro syndrome.
Naveen Kumar, Jeremy Johnson, Susanne Watkins, Eoin Mulroy   +3 more
wiley   +1 more source